Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Semin Cancer Biol. 2019 Aug 21;67(Pt 1):57–64. doi: 10.1016/j.semcancer.2019.08.027

Figure 2:

Figure 2:

Normalized SOX4 expression across 1,321 prostate cancer samples. Indolent prostate cancers have gleason scores (GS) < 7, while aggressive prostate cancers have GS ≥ 7. SOX4 expression is sharply increased in prostate cancer metastases.